Trial Profile
A study of rivaroxaban and clopidogrel in patients after iliofemoral post-thrombotic venous obstruction stenting.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Feb 2018
Price :
$35
*
At a glance
- Drugs Clopidogrel (Primary) ; Rivaroxaban (Primary)
- Indications Restenosis; Stent thrombosis
- Focus Therapeutic Use
- 19 Feb 2018 New trial record